BioboostXBioboostX Facebook ad: “Most metabolic drugs target one receptor.”
Ran for 1 day, from March 9 to March 10, 2026, the last day Crush saw it.
Run by BioboostX on Instagram. Crush is not the advertiser and does not verify its claims. See this ad in Meta's Ad Library(opens in a new tab)
Want an ad like this for your product?
Crush makes new ad images for your product from this ad: your logo, your product photo, your offer.
Trials from $19.95 USD, then $79.95 USD a month. Cancel anytime.
About this ad
- Meta Ad Library ID
- 1632633724607668
- Platforms
- Relaunches
- 1
- EU reach
- 4,917
Ad text
Most metabolic drugs target one receptor. Retatrutide is being studied for something different. Instead of activating a single metabolic pathway, this investigational peptide interacts with three receptors at once: GLP-1 GIP Glucagon Each of these receptors plays a role in metabolic signaling. GLP-1 influences appetite regulation. GIP is involved in nutrient processing. Glucagon participates in energy mobilization. By engaging multiple signaling pathways, researchers are studying whether broader metabolic regulation may be possible compared to single-receptor approaches. But the real story isn’t just the molecule. It’s the biology behind the signaling systems. Understanding how metabolic pathways interact is what makes modern peptide research so interesting. If you want to explore how these compounds work, we built something for that. Save this post so you can revisit the mechanism later. And if you want deeper breakdowns, explore the BioBoostX Research Library where we map peptide mechanisms, pathways and research stages. Link in bio. Follow @BioBoostX for structured peptide research. #bioboostx #peptides #metabolichealth #peptide
